DAPA-CKD: The Beginning of a New Era in Renal Protection

por Cherney, David Z.I., Verma, Subodh
Publicado 2021

Evolution of Renal Hyperfiltration and Arterial Stiffness From Adolescence Into Early Adulthood in Type 1 Diabetes

por Cherney, David Z.I., Sochett, Etienne B.
Publicado 2011

Response to Comment on: Cherney and Sochett. Evolution of Renal Hyperfiltration and Arterial Stiffness From Adolescence Into Early Adulthood in Type 1 Diabetes. Diabetes Care 2011;...

por Cherney, David Z.I., Sochett, Etienne B.
Publicado 2011

Sodium-Glucose Cotransporter-2 Inhibitors in Nephrology Practice: A Narrative Review

por Dubrofsky, Lisa, Srivastava, Anand, Cherney, David Z.
Publicado 2020

Renal physiology of glucose handling and therapeutic implications

por Cherney, David Z, Kanbay, Mehmet, Lovshin, Julie A
Publicado 2020

Making a case for the combined use of SGLT2 inhibitors and GLP1 receptor agonists for cardiorenal protection

por Sridhar, Vikas S., Dubrofsky, Lisa, Boulet, Jacinthe, Cherney, David Z.
Publicado 2020

Sex Differences in Renal Responses to Hyperglycemia, l-Arginine, and l-NMMA in Humans With Uncomplicated Type 1 Diabetes

por Cherney, David Z.I., Scholey, James W., Sochett, Etienne B.
Publicado 2013

Preventing CKD in Developed Countries

por Luyckx, Valerie A., Cherney, David Z.I., Bello, Aminu K.
Publicado 2019

Tubuloglomerular Feedback in Renal Glucosuria: Mimicking Long-term SGLT-2 Inhibitor Therapy

por Neuwirt, Hannes, Burtscher, Andrea, Cherney, David, Mayer, Gert, Ebenbichler, Christoph
Publicado 2019

Prescribing SGLT2 Inhibitors in Patients With CKD: Expanding Indications and Practical Considerations

por Yau, Kevin, Dharia, Atit, Alrowiyti, Ibrahim, Cherney, David Z.I.
Publicado 2022

Prescribing SGLT2 Inhibitors in Patients With CKD: Expanding Indications and Practical Considerations

por Yau, Kevin, Dharia, Atit, Alrowiyti, Ibrahim, Cherney, David Z.I.
Publicado 2022

Renal Hyperfiltration and Systemic Blood Pressure in Patients with Uncomplicated Type 1 Diabetes Mellitus

por Yang, Gary K., Maahs, David M., Perkins, Bruce A., Cherney, David Z. I.
Publicado 2013

A randomized cross-over comparison of short-term exposure of once-daily extended release tacrolimus and twice-daily tacrolimus on renal function in healthy volunteers

por Zaltzman, Jeffrey S, Lai, Vesta, Schulz, Miklos Z, Moon, Kyung-Hee, Cherney, David Z
Publicado 2014

Cardiorenal Protection in Diabetic Kidney Disease

por Lee, Jason F., Berzan, Ecaterina, Sridhar, Vikas S., Odutayo, Ayodele, Cherney, David Z.I.
Publicado 2021

SGLT2 Inhibition in Patients With Type 2 Diabetes Mellitus Post-Nephrectomy: A Single-Center Case Series

por Škrtić, Marko, Cherney, David Z. I., Sridhar, Vikas S., Chan, Christopher T. M., Kitchlu, Abhijat
Publicado 2021

The Acute Effect of Clamped Hyperglycemia on the Urinary Excretion of Inflammatory Cytokines/Chemokines in Uncomplicated Type 1 Diabetes: A pilot study

por Cherney, David Z.I., Scholey, James W., Sochett, Etienne, Bradley, Timothy J., Reich, Heather N.
Publicado 2011

The effect of sodium/glucose cotransporter 2 (SGLT2) inhibition on the urinary proteome

por Cherney, David, Perkins, Bruce A., Lytvyn, Yuliya, Heerspink, Hiddo, Rodríguez-Ortiz, María E., Mischak, Harald
Publicado 2017

Effect of Direct Renin Inhibition on Renal Hemodynamic Function, Arterial Stiffness, and Endothelial Function in Humans With Uncomplicated Type 1 Diabetes: A pilot study

por Cherney, David Z.I., Lai, Vesta, Scholey, James W., Miller, Judith A., Zinman, Bernard, Reich, Heather N.
Publicado 2010

Effects of the SGLT‐2 inhibitor dapagliflozin on glomerular and tubular injury markers

por Dekkers, Claire C. J., Petrykiv, Sergei, Laverman, Gozewijn D., Cherney, David Z., Gansevoort, Ron T., Heerspink, Hiddo J. L.
Publicado 2018

Proceedings From a Canadian Nephrology Forum: Nephrology Is Back

por Levin, Adeera, Sapir, Daniel, Steele, Andrew, Cherney, David, Hellstrom, Ian C., Lanktree, Matthew B., Moist, Louise, Suri, Rita S.
Publicado 2020